ACR Open Rheumatology Rheumatology

A Multicenter, Double‐Blind, Phase 3 Study of the Efficacy and Safety of Anifrolumab in Myositis: Rationale and Design of the JASMINE Trial

Rohit Aggarwal, Hector Chinoy, Ingrid E. Lundberg, Masataka Kuwana, Ruth Ann Vleugels, Consuelo Anzilotti, Andrew Beaton, Celeste Cummings, Tina Luu, Maroua Benghoul
Wiley · 2026-11-19 · DOI 10.1002/acr2.90155

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →